QuantumScape Earnings Misses Estimates

QuantumScape’s earnings fell short of expectations in the fourth quarter as the company issued adjusted-EBITDA and capital-expenditure guidance while advancing commercialization by launching a pilot production line for its QSE-5 solid-state battery cells.

Quarter Results and Guidance

QuantumScape reported fourth-quarter GAAP operating expenses of $110.5 million, a GAAP net loss of $100.1 million, and an adjusted-EBITDA loss of $63.3 million, the company said in a press release on Feb. 11, 2026. The GAAP loss per share was $0.17, about $0.01 below estimates. The quarter’s expenses reflect ongoing investment as the company shifts toward pilot production.

For the full year 2025, GAAP operating expenses totaled $472.6 million and the GAAP net loss was $435.1 million. The adjusted-EBITDA loss narrowed to $252.3 million, roughly a 10% improvement from $285 million the prior year, and fell within the company’s guidance.

QuantumScape guided 2026 adjusted-EBITDA loss to a range of $250 million to $275 million and forecast capital expenditures of $40 million to $60 million. Most CapEx will support development beyond QSE-5, with additional spending aimed at customer and market expansion.

The company ended 2025 with $970.8 million in liquidity and recorded first customer billings of $19.5 million, cash received and reported to equity under related-party accounting. Billings are expected to increase as engagements deepen but remain uneven and are not a substitute for GAAP revenue. Together with the guidance, the liquidity position frames near-term funding and cost priorities.

Eagle Line Pilot and Commercial Progress

QuantumScape baselined its Cobra process in June 2025 and inaugurated a highly automated Eagle Line pilot in San Jose on Feb. 4, 2026. The company said the line incorporates the Cobra process and serves as a blueprint for QSE-5 production. The event drew customers, partners, and government officials, highlighting the company’s push toward commercial validation.

The company shipped Cobra-based QSE-5 samples—cells of roughly 5.6 ampere-hours and about 21 watt-hours per cell—to PowerCo (Volkswagen). It expanded commercial engagements to include two additional global automakers and suppliers Murata and Corning, aiming to deepen testing and partner integration.

Management prioritized scaling Eagle Line uptime, yields, and cost; advancing automotive commercialization; expanding into non-auto markets such as data centers, robotics, aviation, and defense; and improving technology beyond QSE-5. These operational goals align with the guidance and year-end liquidity, linking manufacturing milestones to QuantumScape’s near-term financial plan.